New York State Common Retirement Fund’s Entrada Therapeutics TRDA Stock Holding History

New York State Common Retirement Fund’s Portfolio TRDA Stock Details TRDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.3K	Hold	8,877	–	–	﹤0.01%	2883
2026 Q1	$112K	Hold	8,877	–	–	﹤0.01%	2474
2025 Q4	$91.3K	Hold	8,877	–	–	﹤0.01%	2649
2025 Q3	$51.5K	Hold	8,877	–	–	﹤0.01%	2941
2025 Q2	$59.7K	Hold	8,877	–	–	﹤0.01%	2891
2025 Q1	$80.2K	Hold	8,877	–	–	﹤0.01%	2616
2024 Q4	$153K	Hold	8,877	–	–	﹤0.01%	2418
2024 Q3	$142K	Hold	8,877	–	–	﹤0.01%	2445
2024 Q2	$126K	Hold	8,877	–	–	﹤0.01%	2627
2024 Q1	$126K	Hold	8,877	–	–	﹤0.01%	2641
2023 Q4	$134K	Sell	8,877 -48	-0.5%	-$711	﹤0.01%	2613
2023 Q3	$141K	Buy	8,925 +225	+3%	+$3.54K	﹤0.01%	2572
2023 Q2	$132K	Buy	+8,700	New	+$120K	﹤0.01%	2677
2022 Q3	–	Sell	-109	Closed	-$1K	–	3446
2022 Q2	$1K	Sell	109 -4,771	-98%	-$36.2K	﹤0.01%	3411
2022 Q1	$46K	Buy	+4,880	New	+$52.3K	﹤0.01%	3188

Other funds holding TRDA

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

New York State Common Retirement Fund's TRDA Position: Q2 2026 in Review

New York State Common Retirement Fund held its Entrada Therapeutics (TRDA) position steady in Q2 2026 at 8,877 shares worth $65.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2883.

New York State Common Retirement Fund first reported a position in TRDA in Q1 2022 and has held it in 15 quarters since. The position peaked at $153K in Q4 2024. 22 funds tracked by Wall St. Rank hold TRDA as of Q2 2026.

New York State Common Retirement Fund held 8,877 shares of Entrada Therapeutics worth $65.3K as of Q2 2026.
New York State Common Retirement Fund left its Entrada Therapeutics share count unchanged in Q2 2026.
Entrada Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2883 holding.
New York State Common Retirement Fund first reported a position in Entrada Therapeutics in Q1 2022 and has held it in 15 quarters since.
New York State Common Retirement Fund's Entrada Therapeutics position peaked at $153K in Q4 2024.
22 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.